Education
About Us
Working with TipRanks
Follow Us
Mind Medicine Inc. (MNMD)
NASDAQ:MNMD
Mm402 (R-Enantiomer Of 3,4-Methylenedioxymethamphetamine (Mdma))
Autism Spectrum Disorder, Asd
Phase II
Recruiting
A Phase 2A Trial of MM402 for Autism Spectrum Disorder
Dec 22, 2025
―
Mm-120 (Lsd D-Tartrate)
Anxiety Generalized
Phase II
Completed
A Dose-Finding Study of MM-120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
May 27, 2022
―
Mm-120
Adhd, Attention Deficit Disorder
Phase II
Completed
Safety and Efficacy of Low Dose MM-120 for ADHD Proof of Concept Trial
Dec 21, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Mind Medicine Inc. (MNMD) have in its pipeline
MNMD is currently developing the following drugs: Mm402 (R-Enantiomer Of 3,4-Methylenedioxymethamphetamine (Mdma)), Mm120 (Lsd D-Tartrate), Mm120 (Lsd D-Tartrate). These drug candidates are in various stages of clinical development as the company works toward FDA approval.